Studies of hypoxemic/reoxygenation injury with aortic clamping. XI. Cardiac advantages of normoxemic versus hyperoxemicmanagement during cardiopulmonary bypass

The Journal of Thoracic and Cardiovascular Surgery

Volumn 110, Issue 4 PART 2, 1995, Pages 1255-1264

  Ihnken, Kai ^a   Morita, Kiyozo ^a   Buckberg, Gerald D ^a   Young, Helen H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD OXYGENATION; CARDIOPLEGIA; CONTROLLED STUDY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; HYPOXEMIA; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE; TREATMENT PLANNING;

ALKADIENES; ANIMAL; ANOXEMIA; AORTA; CARDIOPULMONARY BYPASS; CONSTRICTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXYGEN; SUPPORT, NON-U.S. GOV'T; SWINE;

EID: 0028822106     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(95)70012-9     Document Type: Article

References (40)

1. Studies of hypoxemic/reoxygenation injury without aortic clamping. II. Evidence for reoxygenation damage
2. Role of L-arginine–nitric oxide pathway in myocardial reoxygenation injury
3. Cardiopulmonary dysfunction produced by reoxygenation of immature hypoxemic animals on cardiopulmonary bypass: prevention by intravenous metabolic pretreatment
4. Evidence of myocardial free radical injury during elective repair of tetralogy of Fallot
5. Studies of myocardial protection in the immature heart: V. Safety of prolonged aortic clamping with hypocalcemic glutamate/aspartate blood cardioplegia
6. Studies of hypoxemia/reoxygenation injury with aortic clamping. X. Exogenous antioxidants to avoid nullification of the cardioprotective effects of blood cardioplegia
7. Studies of hypoxemic/reoxygenation injury without aortic clamping VI Counteraction of oxidant damage by exogenous antioxidants mercaptoprionyl gycine and catalase
8. Studies of hypoxemia/reoxygenation injury without aortic clamping. VII. Counteraction of oxidant damage by exogenous antioxidants: co-enzyme Q10
9. Studies of hypoxemic/reoxygenation injury: without aortic clamping. IV. Role of the iron-catalyzed pathway: deferoxamine
10. Correlation between antioxidant changes during hypoxia and recovery on reoxygenation
11. Enzyme release and mitochondrial activity in reoxygenated cardiac muscle: relationship with oxygen-induced lipid peroxidation
12. Neutrophils delay functional recovery of the post-hypoxic heart of the rabbit
13. The oxygen paradox and the calcium paradox: two facets of the same problem?
14. Vascular effects of oxygen-derived free radicals
15. Studies of hypoxemic/reoxygenation injury without aortic clamping. IX. Importance of avoiding perioperative hyperoxemia in the setting of previous cyanosis
16. Effect of oxygen tension and cardiovascular operations on the myocardial antioxidant enzyme activities in patients with tetralogy of Fallot and aorta-coronary bypass
17. Diffuse pulmonary opacification in infants undergoing extracorporeal membrane oxygenation: clinical and pathologic correlation
18. Severe myocardial dysfunction during extracorporeal membrane oxygenation
19. Cardiac stun in infants undergoing extracorporeal membrane oxygenation
20. Neuroprotective effect of graded reoxygenation following chronic hypoxia in neuronal cell culture
21. Interactive software for analysis of global or segmental cardiac systolic and diastolic performance by pressure-volume (dimension) relations
22. Superoxide dismutase decreases early reperfusion release of conjugated dienes following regional canine ischemia
23. Altered antioxidant status in the ischemic/reperfused rabbit myocardium: effects of allopurinal
24. Studies of controlled reperfusion after ischemia. II. Biochemical studies: failure of tissue ATP to predict recovery of contractile function after controlled reperfusion
25. Strategies and logic of cardioplegic delivery to prevent, avoid, and reverse ischemic and reperfusion damage
26. Acute myocardial infarction: a decade of experience with surgical reperfusion in 701 patients
27. Advantages of blood cardioplegia over continuous coronary perfusion and intermittent ischemia
28. Myocardial protection during cardiac operations
29. Studies of controlled reperfusion after ischemia: XVI. Early recovery of regional wall motion in patients following surgical revascularization after eight hours of acute coronary occlusion
30. Porcine models in surgical research: an overview
31. Role of oxygen in the cellular damage induced by reoxygenation of hypoxic heart
32. Chronic hypoxemia depresses global ventricular function and predisposes to depletion of high energy phosphates during cardioplegic arrest: implications for surgical repair of cyanotic congenital heart defects
33. Myocardial protection in cyanotic neonatal lambs
34. Effect of oxygen tension on the anti-oxidant enzyme activities of tetralogy of fallot ventricular myocytes
35. Hypoxemic-reoxygenation injury in the immature heart is reducible by reoxygenation with antioxidants
36. Studies of hypoxemic/reoxygenation injury without aortic clamping. V. Role of the L-arginine–nitric oxide pathway: the nitric oxide pathway
37. Studies of myocardial protection in the immature heart: IV. Improved tolerance of immature myocardium to hypoxia and ischemia by intravenous metabolic support
38. Study of the mechanisms of hydrogen peroxide and hydroxyl free radical–induced cellular injury and calcium overload in cardiac myocytes
39. Free radicals alter ionic calcium levels and membrane phospholipids in cultured rat ventricular myocytes
40. Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts